KFF Health News hears from people who say BPC-157 and other peptides harmed them
Users describe migraines, eye pain and fatigue, while an FDA panel stacked with industry-tied doctors voted to ease limits on six unapproved peptides.
Recap by typeshit. Full story at KFF Health News.